(Total Views: 712)
Posted On: 11/17/2025 8:37:39 AM
Post# of 158792
Largest buy-out in history:
$90B & $120B in today's cost.
Pfizer acquired multiple assets but main target was gaining 100% of the drug patent, that they were already partnered on.
Confirmation of signal upregulating:
Our patent iP becomes most valuable leverage in pharma.
So yea, let others pay the cost of commercializing Leronlimab.
Our core leverage is still in-house.
$90B & $120B in today's cost.
Pfizer acquired multiple assets but main target was gaining 100% of the drug patent, that they were already partnered on.
Confirmation of signal upregulating:
Our patent iP becomes most valuable leverage in pharma.
So yea, let others pay the cost of commercializing Leronlimab.
Our core leverage is still in-house.
(2)
(0)
